Twenty one Chlamydia trachomatis reference strains and 40 clinical isolates belonging to the lymphogranuloma venerum (LGV) and trachoma biovars were genotyped by differential restriction mapping of the major-outer-membrane-protein gene (MOMP) obtained by the polymerase-chain reaction (PCR). A/uI digestion of the PCR product distinguishes eight MOMP-genotypes corresponding to 8 serovars. Six additional enzymes (NlalII, CfoI, EcoRI, HinfI, DdeI and FokI) further permit the discrimination of 10 MOMPgenotypes corresponding to the 10 remaining serovars of the species. Alul alone allows direct typing of 78% of the clinical isolates. AluI digestion patterns of mouse C. trachomatis biovar, a C. pneumoniae and two C. psittaci strains, studied for comparison, were clearly distinguishable from one another and from the C. trachomatis LGV and trachoma strains. These results indicate that
SUMMARY
Twenty one Chlamydia trachomatis reference strains and 40 clinical isolates belonging to the lymphogranuloma venerum (LGV) and trachoma biovars were genotyped by differential restriction mapping of the major-outer-membrane-protein gene (MOMP) obtained by the polymerase-chain reaction (PCR). A/uI digestion of the PCR product distinguishes eight MOMP-genotypes corresponding to 8 serovars. Six additional enzymes (NlalII, CfoI, EcoRI, HinfI, DdeI and FokI) further permit the discrimination of 10 MOMPgenotypes corresponding to the 10 remaining serovars of the species. Alul alone allows direct typing of 78% of the clinical isolates. AluI digestion patterns of mouse C. trachomatis biovar, a C. pneumoniae and two C. psittaci strains, studied for comparison, were clearly distinguishable from one another and from the C. trachomatis LGV and trachoma strains. These results indicate that MOMP genotyping by PCR is a valuable molecular tool for studying C. trachomatis epidemiology.
INTRODUCTION
The species Chlamydia trachomatis is divided into three biovars: mouse, lymphogranuloma venerum (LGV), and trachoma [1] . C. trachomatis strains infecting humans (LGV and trachoma biovat isolates) represent an important morbidity factor worldwide, as they are responsible for blinding trachoma, genito-urinary pathology and neonatal ophtalmitis and pneumonitis [2] . Intraspecies characterization is clearly needed for epidemiological studies and for understanding the pathogenesis of C. trachomatis infection. The LGV and trachoma strains can be serotyped by the microimmunofluorescence (micro-IF) test with polyvalent antisera in 15 serovars classified into three groups: C (C, J, A, H, I), B (B, Ba, D, E, L1, L2), and intermediate (G, F, K, L3) [3] . The major-outer-membrane protein (MOMP) of C. trachomat& bears epitopes implicated in the serovar specificity [4] and micro-IF typing has been improved recently by using MOMP-specific monoclonal antibodies [5] . This latter typing technique allows recognition of all the previously described serovars and identifies three new serovars called Da, Ia and L2a because of their respective antigenic relationship to D, I and L2 serovars [6] . Molecular typing based upon the analysis of restriction-fragment length polymorphism (RFLP) of total DNA with a battery of restriction enzymes has also been reported [7] . Distinct fragments, unique to each serovar, allowed differentiation of strains from one serovar to another. However, the limit of all these typing methods is that cell cultures with or without chlamydial purification are necessary, both being costly and time-consuming. Furthermore, serotyping requires access to specific reagents of restricted availability.
More recently, the polymerase-chain reaction (PCR) has been applied to the detection and differentiation of the three Chlamydia species by using primers specific for the MOMP gene [8, 9] . Comparison of the MOMP-gene nucleotide sequences among C. trachomatis serovars has revealed four symmetrically spaced variable domains (VD) designated VD I to VD 4 which precisely correspond to dominant immunologic determinants [10] . In this paper, we describe a genotyping scheme for C. trachomatis based on the differential restriction mapping of the MOMP-gene obtained after PCR.
MATERIALS AND METHODS

Chlamydia
The following reference-C, trachomatis 
PCR analysis of the MOMP gene
DNA was obtained by lysis of 1-10 /xl of unpurified chlamydial preparation in 250 /xl of a buffer containing 50 mM KC1, 10 mM Tris • HC1 (pH 8.3), 2.5 mM MgCI 2, 0.45% Nonidet P-40, 0.45% Tween 20 and 60 /xg/ml of proteinase K. Positive displacement pipettes were used to minimize sample carry-over and samples were prepared in a dedicated externally vented hood. The DNA preparation was incubated at 56 °C for 60 rain and proteinase K was heat-inactivated at 95°C for 10 rain. A pair of oligonucleotide primers for the MOMP gene, CTU/CTL (CTU, 5'-ATGAAAAAACTC TTGAAATCGG-3'; CTL, 5'-CAAGAT TTTCTA GA(T/C) TTCAT-(C/T)TTGTT-3') was chosen in the highly conserved regions of the published DNA sequences for the MOMP gene of C. trachomatis [10, 17] , C. psittaci [18, 19] and C. pneumoniae [20] strains. It allows amplification of a 1-kbp-DNA fragment. Oligonucleotides were synthesized by the phosphoramidite method on a DNA synthesizer (Applied Biosystems, Foster City, CA). Twenty five /xl of the DNA preparation were subjected to PCR in a final reaction mixture containing 10 mM Tris. HC1, pH 8.3; 200 p,M (each dATP, dCTP, dGTP, dTTP; 200 p,M (each) CTU and CTL; 2.5 mM MgCI2; 50 mM KCl; and 2.5 units of Thermus aquaticus DNA polymerase (Perkin Elmer-Cetus, Norwalk, CT) overlayed with 100 txl of mineral oil. In order to improve specificity, DNA was added last after heating the amplification mixture at 80°C [21] . Samples were subjected to 30 cycles of amplification in a DNA Thermal Cycler (Perkin Elmer-Cetus). Cycling conditions were as follows: denaturation, 1 rain at 94°C; primer annealing, 1 min at 48°C and primer extension, 2 rain at 72 ° C. Three negative controls were systematically included in each series: a non-infected egg or celt preparation, lysis buffer with proteinase K alone, and water. To quences [10] [11] [12] [13] [14] [15] [16] [17] from which this scheme was devised (Table I ). The AluI pattern we obtained for serovar C is undistinguishable from the serovar-J pattern. Its fits the sequence data published by Yuan et al. [10] , but not that reported by Stephens et al. [11] . C. trachomatis L2a and Da strains have not been tested in the present study. Patterns obtained with the C. pneumoniae, C. psittaci and mouse C. trachomatis strains were clearly distinguishable from each other and from the C. trachomatis trachoma and LGV biovar strains (Fig. 2) . Those patterns were in accordance with the published MOMP sequences [18] [19] [20] . Fragment sizes given in Table 1 for the mouse C. trachomatis biovar (MoPn) were those deduced from our experimental data since, to our knowledge, the MOMP-gene of this strain has not yet been sequenced. By using this typing strategy, the 40 C. trachomatis clinical strains could be unam- [10] .
biguously typed to 9 MOMP-genotypes (Ba, D, E, F, G, H, Ia, J and K) by identity with the reference strains patterns. Use of AluI and AluI/CfoI allowed the typing of 78% and 83% of the strains, respectively.
In conclusion, by using a typing scheme based upon differential restriction mapping of the MOMP-gene, similar to those previously reported for polymorphic loci such as the human-HLA genes [22] , we were able to distinguish all 18 C. trachomatis serovars with 6 restriction enzymes. However, taking into account eh epidemiological data previously reported in developed countries [5, 23, 24] 
